More articles from Respiratory infections and bronchiectasis

Pathogenetic treatment of patients with new coronavirus infection COVID-19
Ludmila Shovkun, Dmitry Kudlay, Nikolai Nikolenko, Elena Kampos

European Respiratory Journal Sep 2021, 58 (suppl 65) PA801; DOI: 10.1183/13993003.congress-2021.PA801
Lymphocyte-to-monocyte ratio (LMR) as a predictor of Covid-19 pneumonia progression
Daria Koval, Tetyana Pertseva, Lyudmila Konopkina, Kseniia Bielosludtseva, Mariia Krykhtina

European Respiratory Journal Sep 2021, 58 (suppl 65) PA651; DOI: 10.1183/13993003.congress-2021.PA651
The first experience of anti-IL6 administration for COVID-19 infection
Alexander Vizel, Diana Abdulganieva, Ainagul Bayalieva, Irina Vizel

European Respiratory Journal Sep 2021, 58 (suppl 65) PA802; DOI: 10.1183/13993003.congress-2021.PA802
Dexamethasone in patients hospitalized with COVID-19: a NNT and NNH analysis of RECOVERY study
Luigino Calzetta, Marina Aiello, Paola Rogliani, Alfredo Chetta

European Respiratory Journal Sep 2021, 58 (suppl 65) PA815; DOI: 10.1183/13993003.congress-2021.PA815
Factors associated with poor glycemic control in patients hospitalised for COVID-19
Stefan-Marian Frent, Emanuel Bobu, Roxana Pleava, Costela Serban, Iosif Marincu, Virgil Musta, Stefan Mihaicuta, Ovidiu Fira-Mladinescu, Diana Manolescu, Cristian Oancea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA526; DOI: 10.1183/13993003.congress-2021.PA526
Association between creatine kinase level and mortality in high-risk patients with COVID-19
Aram Kitbalian, Michael Brovko, Larisa Akulkina, Pavel Potapov, Alexey Moiseev, Anastasia Schepalina, Alexandra Yakovleva, Viktoria Sholomova, Sergey Moiseev

European Respiratory Journal Sep 2021, 58 (suppl 65) PA650; DOI: 10.1183/13993003.congress-2021.PA650
Predictive factors for disease progression in moderate to severe COVID-19 patients
nouha boubaker, Sabrine Louhaichi, Ikbel Khalfallah, Safa Belkhir, Mariem Ferchichi, Jamel Ammar, Besma Hamdi, Agnès Hamzaoui

European Respiratory Journal Sep 2021, 58 (suppl 65) PA809; DOI: 10.1183/13993003.congress-2021.PA809
A single centre study of COVID-19 patients: correlation with DDIMER and outcomes
Indrajit Sau, Ehsaan Qureshi, Muhammad Arif Khalil, Stanley Ejiofor

European Respiratory Journal Sep 2021, 58 (suppl 65) PA803; DOI: 10.1183/13993003.congress-2021.PA803
The prognostic value of procalcitonin in patients with hypoxemic COVID 19 pneumonia
Islam Mejri Ep Ajili, Nouha Boubaker, Hager Kchouk, Samira Mhamdi, Selsabil Daboussi, Chiraz Aichaouia, Zied Moatemri, Mohsen Khadhraoui

European Respiratory Journal Sep 2021, 58 (suppl 65) PA658; DOI: 10.1183/13993003.congress-2021.PA658
Experience of olokizumab use in COVID-19 patients
Vladimir Antonov, Galina Ignatova, Semen Zotov

European Respiratory Journal Sep 2021, 58 (suppl 65) PA817; DOI: 10.1183/13993003.congress-2021.PA817

Main menu

User menu

Search

More articles from Respiratory infections and bronchiectasis

Pages

Contact us